Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation

References

• Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi:10.3402/jev.v4.2706625979354
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.12529339798
   PubMed Web of Science ®Google Scholar
• Agrahari V, Agrahari V, Burnouf PA, Chew CH, Burnouf T. Extracellular microvesicles as new industrial therapeutic frontiers. Trends Biotechnol. 2019;37:707–729. doi:10.1016/j.tibtech.2018.11.01230638682
   PubMedGoogle Scholar
• Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172–188. doi:10.1016/j.tcb.2016.11.00327979573
   PubMed Web of Science ®Google Scholar
• de Jong OG, Kooijmans SAA, Murphy DE, et al. Drug delivery with extracellular vesicles: from imagination to innovation. Acc Chem Res. 2019;52:1761–1770. doi:10.1021/acs.accounts.9b0010931181910
   PubMed Web of Science ®Google Scholar
• Vader P, Mol EA, Pasterkamp G, Schiffelers RM. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 2016;106(Pt A):148–156. doi:10.1016/j.addr.2016.02.00626928656
   PubMed Web of Science ®Google Scholar
• Gudbergsson JM, Jonsson K, Simonsen JB, Johnsen KB. Systematic review of targeted extracellular vesicles for drug delivery - considerations on methodological and biological heterogeneity. J Control Release. 2019;306:108–120. doi:10.1016/j.jconrel.2019.06.00631175896
   PubMed Web of Science ®Google Scholar
• Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087. doi:10.3402/jev.v4.3008726725829
   PubMed Web of Science ®Google Scholar
• Pachler K, Lener T, Streif D, et al. A good manufacturing practice–grade standard protocol for exclusively human mesenchymal stromal cell–derived extracellular vesicles. Cytotherapy. 2017;19(4):458–472. doi:10.1016/j.jcyt.2017.01.00128188071
   PubMed Web of Science ®Google Scholar
• Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63. doi:10.1186/s13287-018-0791-729523213
   PubMed Web of Science ®Google Scholar
• Burnouf T, Goubran HA, Chou ML, Devos D, Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev. 2014;28(4):155–166.24826991
   PubMed Web of Science ®Google Scholar
• Tao SC, Guo SC, Zhang CQ. Platelet-derived extracellular vesicles: an emerging therapeutic approach. Int J Biol Sci. 2017;13(7):828–834. doi:10.7150/ijbs.1977628808416
   PubMed Web of Science ®Google Scholar
• Burnouf T, Burnouf PA, Wu YW, Chuang EY, Lu LS, Goubran H. Circulatory-cell-mediated nanotherapeutic approaches in disease targeting. Drug Discov Today. 2018;23(5):934–943. doi:10.1016/j.drudis.2017.08.01228917821
   PubMedGoogle Scholar
• Palviainen M, Saari H, Karkkainen O, et al. Metabolic signature of extracellular vesicles depends on the cell culture conditions. J Extracell Vesicles. 2019;8(1):1596669. doi:10.1080/20013078.2018.156080831007875
   PubMed Web of Science ®Google Scholar
• Gimona M, Pachler K, Laner-Plamberger S, Schallmoser K, Rohde E. Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci. 2017;18(6). doi:10.3390/ijms18061190
   Web of Science ®Google Scholar
• Pascucci L, Coccè V, Bonomi A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014;192:262–270. doi:10.1016/j.jconrel.2014.07.04225084218
   PubMed Web of Science ®Google Scholar
• Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35(7):2383–2390. doi:10.1016/j.biomaterials.2013.11.08324345736
   PubMed Web of Science ®Google Scholar
• Yang T, Martin P, Fogarty B, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio Rerio. Pharm Res. 2015;32(6):2003–2014. doi:10.1007/s11095-014-1593-y25609010
   PubMed Web of Science ®Google Scholar
• Liao W, Du Y, Zhang C, et al. Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater. 2019;86:1–14. doi:10.1016/j.actbio.2018.12.04530597259
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine. 2016;12(3):655–664. doi:10.1016/j.nano.2015.10.01226586551
   PubMed Web of Science ®Google Scholar
• Sato YT, Umezaki K, Sawada S, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6:21933. doi:10.1038/srep2193326911358
   PubMed Web of Science ®Google Scholar
• Kim SM, Kim HS. Engineering of extracellular vesicles as drug delivery vehicles. Stem Cell Investig. 2017;4:74. doi:10.21037/sci.2017.08.07
   PubMedGoogle Scholar
• Tang TT, Lv LL, Lan HY, Liu BC. Extracellular vesicles: opportunities and challenges for the treatment of renal diseases. Front Physiol. 2019;10:226. doi:10.3389/fphys.2019.0022630941051
   PubMedGoogle Scholar
• Paganini C, Palmiero UC, Pocsfalvi G, Touzet N, Bongiovanni A, Arosio P. Scalable production and isolation of extracellular vesicles: available sources and lessons from current industrial bioprocesses. Biotechnol J. 2019;e1800528. doi:10.1002/biot.20180052831140717
   PubMedGoogle Scholar
• Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347. doi:10.1155/2018/854534729662902
   PubMed Web of Science ®Google Scholar
• Busatto S, Vilanilam G, Ticer T, et al. Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid. Cells. 2018;7(12):273. doi:10.3390/cells7120273
   PubMed Web of Science ®Google Scholar
• Watson DC, Yung BC, Bergamaschi C, et al. Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes. J Extracell Vesicles. 2018;7(1):1442088. doi:10.1080/20013078.2018.144208829535850
   PubMed Web of Science ®Google Scholar
• Boing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3. doi:10.3402/jev.v3.24384
   Google Scholar
• Ramirez MI, Amorim MG, Gadelha C, et al. Technical challenges of working with extracellular vesicles. Nanoscale. 2018;10(3):881–906. doi:10.1039/c7nr08360b29265147
   PubMed Web of Science ®Google Scholar
• Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347. doi:10.1155/2018/854534729662902
   PubMed Web of Science ®Google Scholar
• Liang K, Liu F, Fan J, et al. Nanoplasmonic quantification of tumor-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring. Nat Biomed Eng. 2017;1. doi:10.1038/s41551-016-0021
   PubMed Web of Science ®Google Scholar
• Sunkara V, Woo HK, Cho YK. Emerging techniques in the isolation and characterization of extracellular vesicles and their roles in cancer diagnostics and prognostics. Analyst. 2016;141(2):371–381. doi:10.1039/c5an01775k26535415
   PubMed Web of Science ®Google Scholar
• Hartjes TA, Mytnyk S, Jenster GW, van Steijn V, van Royen ME. Extracellular vesicle quantification and characterization: common methods and emerging approaches. Bioengineering. 2019;6(1):7. doi:10.3390/bioengineering6020029
   PubMed Web of Science ®Google Scholar
• Rupert DLM, Claudio V, Lässer C, Bally M. Methods for the physical characterization and quantification of extracellular vesicles in biological samples. Biochim Biophys Acta. 2017;1861(1, Part A):3164–3179. doi:10.1016/j.bbagen.2016.07.028
   Google Scholar
• Szatanek R, Baj-Krzyworzeka M, Zimoch J, Lekka M, Siedlar M, Baran J. The methods of choice for extracellular vesicles (EVs) characterization. Int J Mol Sci. 2017;18(6):1153. doi:10.3390/ijms18061153
   PubMed Web of Science ®Google Scholar
• Klutz S, Magnus J, Lobedann M, et al. Developing the biofacility of the future based on continuous processing and single-use technology. J Biotechnol. 2015;213:120–130. doi:10.1016/j.jbiotec.2015.06.38826091773
   PubMed Web of Science ®Google Scholar
• Rohde E, Pachler K, Gimona M. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. Cytotherapy. 2019;21:581–592. doi:10.1016/j.jcyt.2018.12.00630979664
   PubMed Web of Science ®Google Scholar
• Cai K, Anderson J, Orchard JD, Afdahl CD, Dickson M, Li Y. Virus removal robustness of ion exchange chromatography. Biologicals. 2019;58:28–34. doi:10.1016/j.biologicals.2019.01.00430661901
   PubMedGoogle Scholar
• Burnouf T, Radosevich M. Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev. 2000;14(2):94–110. doi:10.1054/blre.2000.012911012252
   PubMed Web of Science ®Google Scholar
• Chou ML, Lin LT, Devos D, Burnouf T. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment. Transfusion. 2015;55(10):2433–2444. doi:10.1111/trf.1316225988671
   PubMed Web of Science ®Google Scholar
• Burnouf T, Strunk D, Koh MB, Schallmoser K. Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials. 2016;76:371–387. doi:10.1016/j.biomaterials.2015.10.06526561934
   PubMed Web of Science ®Google Scholar
• Henschler R, Gabriel C, Schallmoser K, Burnouf T, Koh MBC. Human platelet lysate current standards and future developments. Transfusion. 2019;59(4):1407–1413. doi:10.1111/trf.1517430741431
   PubMedGoogle Scholar
• Schallmoser K, Henschler R, Gabriel C, Koh MBC, Burnouf T. Production and quality requirements of human platelet lysate: a position statement from the working party on cellular therapies of the international society of blood transfusion. Trends Biotechnol. 2019. doi:10.1016/j.tibtech.2019.06.002
   PubMedGoogle Scholar
• Aranha H. Virus safety of biopharmaceuticals - absence of evidence is not evidence of absence. Contract Pharma. 2011;13:82–87.
   Google Scholar
• Moody M, Alvez W, Varghese J, Khan F. Mouse Minute Virus (MMV) contamination—a case study: detection, root cause determination, and corrective actions. PDA J Pharm Sci Technol. 2011;65(6):580–588. doi:10.5731/pdajpst.2011.0082422294580
   PubMedGoogle Scholar
• Kerr A, Nims R. Adventitious viruses detected in biopharmaceutical bulk harvest samples over a 10 year period. PDA J Pharm Sci Technol. 2010;64(5):481–485.21502056
   PubMedGoogle Scholar
• Roush JD. Integrated viral clearance strategies — reflecting on the present, projecting to the future. Curr Opin Biotechnol. 2018;53:137–143. doi:10.1016/j.copbio.2018.01.00329367164
   PubMedGoogle Scholar
• Carbrello C, Nhiem D, Priest M, Mann K, Greenhalgh P. Supplement: upstream virus safety: protect your bioreactor by media filtration. Genet Eng Biotechnol News. 2017;37(17).
   Google Scholar
• Mann K, Royce J, Carbrello C, et al. Protection of bioreactor culture from virus contamination by use of a virus barrier filter. BMC Proc. 2015;9(9):22. doi:10.1186/1753-6561-9-S9-P22
   Google Scholar
• Wiklander OP, Nordin JZ, O’Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316. doi:10.3402/jev.v4.2631625899407
   PubMed Web of Science ®Google Scholar
• Lai CP, Mardini O, Ericsson M, et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014;8(1):483–494. doi:10.1021/nn404945r24383518
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Nishikawa M, Shinotsuka H, et al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013;165(2):77–84. doi:10.1016/j.jbiotec.2013.03.01323562828
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Takahashi Y, Nishikawa M, et al. Role of phosphatidylserine-derived negative surface charges in the recognition and uptake of intravenously injected B16BL6-derived exosomes by macrophages. J Pharm Sci. 2017;106(1):168–175. doi:10.1016/j.xphs.2016.07.02227649887
   PubMed Web of Science ®Google Scholar
• Imai T, Takahashi Y, Nishikawa M, et al. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J Extracell Vesicles. 2015;4:26238. doi:10.3402/jev.v4.2623825669322
   PubMed Web of Science ®Google Scholar
• Matsumoto J, Stewart T, Banks WA, Zhang J. The transport mechanism of extracellular vesicles at the blood-brain barrier. Curr Pharm Des. 2017;23(40):6206–6214. doi:10.2174/138161282366617091316473828914201
   PubMed Web of Science ®Google Scholar
• Pinheiro A, Silva AM, Teixeira JH, et al. Extracellular vesicles: intelligent delivery strategies for therapeutic applications. J Control Release. 2018;289:56–69. doi:10.1016/j.jconrel.2018.09.01930261205
   PubMedGoogle Scholar
• Munagala R, Aqil F, Jeyabalan J, Gupta RC. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016;371(1):48–61. doi:10.1016/j.canlet.2015.10.02026604130
   PubMed Web of Science ®Google Scholar
• Pieters BC, Arntz OJ, Bennink MB, et al. Commercial cow milk contains physically stable extracellular vesicles expressing immunoregulatory TGF-beta. PLoS One. 2015;10(3):e0121123. doi:10.1371/journal.pone.012112325822997
   PubMed Web of Science ®Google Scholar
• Manca S, Giraud D, Zempleni J. Bioavailability and biodistribution of fluorophore-labeled exosomes from cow’s milk after intravenous and oral administration in C57Bl/6J mice. Faseb J. 2016;30(1_supplement):690.698.
   Google Scholar
• Narbute K, Pilipenko V, Pupure J, et al. Intranasal administration of extracellular vesicles derived from human teeth stem cells improves motor symptoms and normalizes tyrosine hydroxylase expression in the substantia nigra and striatum of the 6-hydroxydopamine-treated rats. Stem Cells Transl Med. 2019;8(5):490–499. doi:10.1002/sctm.18-016230706999
   PubMedGoogle Scholar
• Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19(10):1769–1779. doi:10.1038/mt.2011.16421915101
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. doi:10.1016/j.jconrel.2015.03.03325836593
   PubMed Web of Science ®Google Scholar
• Betzer O, Perets N, Angel A, et al. In vivo neuroimaging of exosomes using gold nanoparticles. ACS Nano. 2017;11(11):10883–10893. doi:10.1021/acsnano.7b0449528960957
   PubMed Web of Science ®Google Scholar
• Ingato D, Lee JU, Sim SJ, Kwon YJ. Good things come in small packages: overcoming challenges to harness extracellular vesicles for therapeutic delivery. J Control Release. 2016;241:174–185. doi:10.1016/j.jconrel.2016.09.01627667180
   PubMed Web of Science ®Google Scholar
• Jeyaram A, Jay SM. Preservation and storage stability of extracellular vesicles for therapeutic applications. Aaps J. 2017;20(1):1. doi:10.1208/s12248-017-0160-y29181730
   PubMed Web of Science ®Google Scholar
• Charoenviriyakul C, Takahashi Y, Nishikawa M, Takakura Y. Preservation of exosomes at room temperature using lyophilization. Int J Pharm. 2018;553(1–2):1–7. doi:10.1016/j.ijpharm.2018.10.03230316791
   PubMedGoogle Scholar
• Park SJ, Jeon H, Yoo SM, Lee MS. The effect of storage temperature on the biological activity of extracellular vesicles for the complement system. In Vitro Cell Dev Biol Anim. 2018;54(6):423–429. doi:10.1007/s11626-018-0261-729748909
   PubMed Web of Science ®Google Scholar
• Richter M, Fuhrmann K, Fuhrmann G. Evaluation of the storage stability of extracellular vesicles. J Vis Exp. 2019;(147). doi:10.3791/59584
   Google Scholar
• Kusuma GD, Barabadi M, Tan JL, Morton DAV, Frith JE, Lim R. To protect and to preserve: novel preservation strategies for extracellular vesicles. Front Pharmacol. 2018;9(1199). doi:10.3389/fphar.2018.01199
   PubMedGoogle Scholar
• Valkonen S, van der Pol E, Boing A, et al. Biological reference materials for extracellular vesicle studies. Eur J Pharm Sci. 2017;98:4–16. doi:10.1016/j.ejps.2016.09.00827622921
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzas EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2:20360.
   PubMedGoogle Scholar
• Lorincz AM, Timar CI, Marosvari KA, et al. Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes. J Extracell Vesicles. 2014;3:25465. doi:10.3402/jev.v3.2438425536933
   PubMedGoogle Scholar
• Jin Y, Chen K, Wang Z, et al. DNA in serum extracellular vesicles is stable under different storage conditions. BMC Cancer. 2016;16(1):753. doi:10.1186/s12885-016-2783-227662833
   PubMedGoogle Scholar
• Bosch S, de Beaurepaire L, Allard M, et al. Trehalose prevents aggregation of exosomes and cryodamage. Sci Rep. 2016;6:36162. doi:10.1038/srep3616227824088
   PubMed Web of Science ®Google Scholar
• Frank J, Richter M, de Rossi C, Lehr CM, Fuhrmann K, Fuhrmann G. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying. Sci Rep. 2018;8(1):12377. doi:10.1038/s41598-018-30786-y30120298
   PubMedGoogle Scholar
• Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617–638. doi:10.1038/s41571-018-0036-929795272
   PubMed Web of Science ®Google Scholar
• Hinde E, Thammasiraphop K, Duong HT, et al. Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release. Nat Nanotechnol. 2017;12(1):81. doi:10.1038/nnano.2016.16027618255
   PubMed Web of Science ®Google Scholar
• Erkoc P, Yasa IC, Ceylan H, Yasa O, Alapan Y, Sitti M. Mobile microrobots for active therapeutic delivery. Adv Ther. 2019;2(1):1800064. doi:10.1002/adtp.v2.1
   Google Scholar
• Brambilla D, Luciani P, Leroux JC. Breakthrough discoveries in drug delivery technologies: the next 30 years. J Control Release. 2014;190:9–14. doi:10.1016/j.jconrel.2014.03.05624794899
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Tavares AJ, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014. doi:10.1038/natrevmats.2016.14
   Web of Science ®Google Scholar
• Kibria G, Ramos EK, Wan Y, Gius DR, Liu H. Exosomes as a drug delivery system in cancer therapy: potential and challenges. Mol Pharm. 2018;15(9):3625–3633. doi:10.1021/acs.molpharmaceut.8b0027729771531
   PubMed Web of Science ®Google Scholar
• Armstrong JPK, Stevens MM. Strategic design of extracellular vesicle drug delivery systems. Adv Drug Deliv Rev. 2018;130:12–16. doi:10.1016/j.addr.2018.06.01729959959
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. doi:10.1038/nature2234128607485
   PubMed Web of Science ®Google Scholar
• You Y, Ikezu T. Emerging roles of extracellular vesicles in neurodegenerative disorders. Neurobiol Dis. 2019;130:104512. doi:10.1016/j.nbd.2019.10451231229685
   PubMed Web of Science ®Google Scholar
• Hall J, Prabhakar S, Balaj L, Lai CP, Cerione RA, Breakefield XO. Delivery of therapeutic proteins via extracellular vesicles: review and potential treatments for Parkinson’s disease, Glioma, and Schwannoma. Cell Mol Neurobiol. 2016;36(3):417–427. doi:10.1007/s10571-015-0309-027017608
   PubMed Web of Science ®Google Scholar
• Budnik V, Ruiz-Cañada C, Wendler F. Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci. 2016;17(3):160–172. doi:10.1038/nrn.2015.2926891626
   PubMed Web of Science ®Google Scholar
• Rufino-Ramos D, Albuquerque PR, Carmona V, Perfeito R, Nobre RJ, Pereira de Almeida L. Extracellular vesicles: novel promising delivery systems for therapy of brain diseases. J Control Release. 2017;262:247–258. doi:10.1016/j.jconrel.2017.07.00128687495
   PubMed Web of Science ®Google Scholar
• Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6(4):287–296. doi:10.1016/j.apsb.2016.02.00127471669
   PubMed Web of Science ®Google Scholar
• Qu M, Lin Q, Huang L, et al. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease. J Control Release. 2018;287:156–166. doi:10.1016/j.jconrel.2018.08.03530165139
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang H-X, He C-P, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149. doi:10.1016/j.biomaterials.2017.10.01229040874
   PubMed Web of Science ®Google Scholar
• Vinaiphat A, Sze SK. Clinical implications of extracellular vesicles in neurodegenerative diseases. Expert Rev Mol Diagn. 2019;1–12.
   Web of Science ®Google Scholar
• Rayyan M, Zheutlin A, Byrd JB. Clinical research using extracellular vesicles: insights from the International Society for Extracellular Vesicles 2018 annual meeting. J Extracell Vesicles. 2018;7(1):1535744. doi:10.1080/20013078.2018.153574431162489
   PubMedGoogle Scholar
• Besse B, Charrier M, Lapierre V, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 2016;5(4):e1071008. doi:10.1080/2162402X.2015.107100827141373
   PubMed Web of Science ®Google Scholar
• Shukla AA, Thommes J. Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol. 2010;28(5):253–261. doi:10.1016/j.tibtech.2010.02.00120304511
   PubMed Web of Science ®Google Scholar
• Armstrong JPK, Holme MN, Stevens MM. Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano. 2017;11(1):69–83. doi:10.1021/acsnano.6b0760728068069
   PubMed Web of Science ®Google Scholar
• Koh E, Lee EJ, Nam GH, et al. Exosome-SIRPalpha, a CD47 blockade increases cancer cell phagocytosis. Biomaterials. 2017;121:121–129. doi:10.1016/j.biomaterials.2017.01.00428086180
   PubMed Web of Science ®Google Scholar
• Riazifar M, Pone EJ, Lotvall J, Zhao W. Stem Cell Extracellular Vesicles: extended Messages of Regeneration. Annu Rev Pharmacol Toxicol. 2017;57:125–154. doi:10.1146/annurev-pharmtox-061616-03014627814025
   PubMed Web of Science ®Google Scholar
• Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev. 2015;11(1):150–160. doi:10.1007/s12015-014-9545-9
   PubMed Web of Science ®Google Scholar
• Agrahari V, Burnouf PA, Burnouf T, Agrahari V. Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential. Adv Drug Deliv Rev. doi:10.1016/j.addr.2019.02.008 Epub 2019 Feb 22.
   Google Scholar
• Agrahari V, Hiremath P. Challenges associated and approaches for successful translation of nanomedicines into commercial products. Nanomedicine (Lond). 2017;12(8):819–823. doi:10.2217/nnm-2017-0039
   Google Scholar